Document is current
Any future updates will be listed below
-
Authors
Ibarluzea, Jesus
Subiza-Pérez, Mikel
Arregi, Ane https://orcid.org/0000-0003-4781-5664
Otamendi, Maialen
Luque-Garcia, Leire
Irizar, Amaia
García-Baquero, Gonzalo
Santa-Marina, Loreto
Lertxundi, Nerea
-
Funding
Funding for this research was provided by:
Instituto de Salud Carlos III (FIS-PI06/0867, FIS-PI09/00090, FIS-PI13/02187, FIS-PI18/01142, FIS-PI18/01237)
CIBERESP
Osasun Saila, Eusko Jaurlaritzako (2005111093, 2009111069, 2013111089, 2015111065, 2018111086)
Diputación Foral de Gipuzkoa (DFG06/002, DFG08/001, DFG15/221, DFG 89/17)
Annual agreements with the municipalities of the study area
Universidad del País Vasco
- License Information
-
More Information
Article History
Received: 27 March 2025
Revised: 1 July 2025
Accepted: 15 July 2025
First Online: 24 August 2025
Declarations
:
: No potential conflict of interest was reported by the authors.
: This study was approved by the Ethics Committee of the Donostia Hospital (Gipuzkoa) and the Ethics Committee for Research with Drugs of the Euskadi (CEIm-E).
: After the content of the study was fully explained and well understood by the infants’ parents, all participating mothers gave written informed consent for themselves and on behalf of their children.
